Each month, we鈥檇 like to highlight some current work at Huntsman Cancer Institute. See how a potential new immunotherapy for breast cancer is being developed, learn about research being done...
When Bret Boyle lost his vision while on vacation in Hawaii, he immediately flew home to be treated. His mantle cell lymphoma has returned. Luckily, the FDA had recently approved...
The Lymphoma Research Foundation selected Daniel Ermann, MD, for the highly competitive Lymphoma Scientific Research Mentoring Program, class of 2023. The foundation awards a career development grant of $10,000 to...
There are many types of blood cancer and one of them is lymphoma. Learn about its symptoms, risk factors, how it is diagnosed, and what treatments are available to you...
Elise Mahaffie was diagnosed with chronic lymphocytic leukemia a decade ago. Her cancer journey has taken her all over the United States. Now living in Wyoming, she makes the trek...
Huntsman Cancer Institute celebrates the addition of two endowed chair holders and a fellowship, as well as the renewal of two esteemed endowed chairs. CEO Mary Beckerle, PhD, congratulates distinguished...
A national authority in hematology will soon lead Hematology and Hematological Malignancies at Huntsman Cancer Institute and 麻豆学生精品版. Dr. Ramiro Garzon's focus is patients with leukemia and...
When Jeanette Nielsen was diagnosed with multiple myeloma, she turned to the professional care teams and clinical trials at Huntsman Cancer Institute. "We knew that clinical trials in the past...
New members added to The Society of Huntsman Translational Scholars. They include Gita Suneja, MD, MS; Siwen Hu-Lieskovan, MD, PhD; and Douglas Sborov, MD, MS.
A unique collection of tissue samples donated by people with chronic myeloid leukemia was the driving force behind the discovery of a potentially major new treatment approach for drug-resistant leukemia...
In pediatric and young adult patients with acute lymphoblastic leukemia (ALL) treated with tisagenlecleucel (Kymriah), DNA sequencing-based detection accurately identified all patients who would eventually relapse, while other methods were...
Younger B-cell non-Hodgkin lymphoma (B-NHL) survivors had a higher relative risk of developing age-related diseases than older B-NHL survivors five years of more after cancer diagnosis, according to results published...
Douglas Sborov, MD, MS, discusses the work being done by the multiple myeloma and clinical trials programs at Huntsman Cancer Institute. He also shares why this work is so meaningful...
Adam Whitt shares experiences about being a professional baseball pitcher and then being diagnosed with chronic myeloid (or myelogenous) leukemia. Now in remission, he is finding success in another sport鈥攇olf.
